<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id><journal-title-group><journal-title>BMC Public Health</journal-title></journal-title-group><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">5709</article-id><article-id pub-id-type="doi">10.1186/s12889-018-5709-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>High-resolution epidemic simulation using within-host infection and contact data</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Nguyen</surname><given-names>Van Kinh</given-names></name><address><email>knguyen@fias.uni-frankfurt.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mikolajczyk</surname><given-names>Rafael</given-names></name><address><email>rafael.mikolajczyk@uk-halle.de</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hernandez-Vargas</surname><given-names>Esteban Abelardo</given-names></name><address><email>vargas@fias.uni-frankfurt.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9721</institution-id><institution-id institution-id-type="GRID">grid.7839.5</institution-id><institution>Frankfurt Institute for Advanced Studies, </institution></institution-wrap>Ruth-Moufang-Str. 1, Frankfurt am Main, 60438 Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7490.a</institution-id><institution>Helmholtz Centre for Infection Research, </institution></institution-wrap>Inhoffen Str. 7, Braunschweig, 38124 Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.452463.2</institution-id><institution>German Centre for Infection Research, </institution></institution-wrap>Site Braunschweig-Hannover, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9529 9877</institution-id><institution-id institution-id-type="GRID">grid.10423.34</institution-id><institution>Hannover Medical School, </institution></institution-wrap>Hannover, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0679 2801</institution-id><institution-id institution-id-type="GRID">grid.9018.0</institution-id><institution>Martin-Luther-University Halle-Wittenberg, </institution></institution-wrap>Halle (Saale), Germany </aff></contrib-group><pub-date pub-type="epub"><day>17</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>18</volume><elocation-id>886</elocation-id><history><date date-type="received"><day>5</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Recent epidemics have entailed global discussions on revamping epidemic control and prevention approaches. A general consensus is that all sources of data should be embraced to improve epidemic preparedness. As a disease transmission is inherently governed by individual-level responses, pathogen dynamics within infected hosts posit high potentials to inform population-level phenomena. We propose a multiscale approach showing that individual dynamics were able to reproduce population-level observations.</p></sec><sec><title>Methods</title><p>Using experimental data, we formulated mathematical models of pathogen infection dynamics from which we simulated mechanistically its transmission parameters. The models were then embedded in our implementation of an age-specific contact network that allows to express individual differences relevant to the transmission processes. This approach is illustrated with an example of Ebola virus (EBOV).</p></sec><sec><title>Results</title><p>The results showed that a within-host infection model can reproduce EBOV&#x02019;s transmission parameters obtained from population data. At the same time, population age-structure, contact distribution and patterns can be expressed using network generating algorithm. This framework opens a vast opportunity to investigate individual roles of factors involved in the epidemic processes. Estimating EBOV&#x02019;s reproduction number revealed a heterogeneous pattern among age-groups, prompting cautions on estimates unadjusted for contact pattern. Assessments of mass vaccination strategies showed that vaccination conducted in a time window from five months before to one week after the start of an epidemic appeared to strongly reduce epidemic size. Noticeably, compared to a non-intervention scenario, a low critical vaccination coverage of 33% cannot ensure epidemic extinction but could reduce the number of cases by ten to hundred times as well as lessen the case-fatality rate.</p></sec><sec><title>Conclusions</title><p>Experimental data on the within-host infection have been able to capture upfront key transmission parameters of a pathogen; the applications of this approach will give us more time to prepare for potential epidemics. The population of interest in epidemic assessments could be modelled with an age-specific contact network without exhaustive amount of data. Further assessments and adaptations for different pathogens and scenarios to explore multilevel aspects in infectious diseases epidemics are underway.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12889-018-5709-x) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>High-resolution</kwd><kwd>Epidemic</kwd><kwd>Simulation</kwd><kwd>Within-host infection</kwd><kwd>Age-structure</kwd><kwd>Contact network</kwd><kwd>Ebola virus</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Alfons und Gertrud Kassel-Stiftung</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Presidents Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF)</institution></funding-source><award-id>VH-GS-202</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Epidemics of infectious diseases are currently listed among the potential catastrophes that can set the world back in the next decades [<xref ref-type="bibr" rid="CR1">1</xref>]. Overwhelming research efforts have been developed to predict the danger of the epidemics but their crisis nature often left scientists no better option than learning from the past [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Confronting outbreaks of emerging infections, however, requires a swift response and thus the ability to evaluate quickly and early possible outcomes [<xref ref-type="bibr" rid="CR1">1</xref>]. As such, computer simulations of epidemic models undoubtedly hold the potential as the first-aid toolbox for decision making amid the crisis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p>Computational approaches in epidemic modelling date back a few centuries ago [<xref ref-type="bibr" rid="CR5">5</xref>]. Since then, an overwhelming amount of research has been conducted and contributed profoundly to understanding of epidemic control and prevention [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The aims of epidemic modelling are to address questions such as whether or not a substantial population fraction is getting infected? how large would the outbreak spread? or how can the outbreak be mitigated with intervention approaches at hand? among others [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Answering these questions requires the quantification of these models using disease data on a population level [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>], which are often delayed [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], under-reported [<xref ref-type="bibr" rid="CR14">14</xref>], or not readily available [<xref ref-type="bibr" rid="CR9">9</xref>]. As a result, epidemic models using population data, while progress understanding on diseases, might have limited applications to an ongoing epidemic [<xref ref-type="bibr" rid="CR15">15</xref>]. A potentially useful way to predict future disease dynamics is using within-host processes [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>In reality, the within-host infection process determines key parameters in a disease transmission ([<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>], Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). In an infected subject, interactions between the pathogen and immune responses shape the pathogen dynamics which, ultimately, define the incubation period, the transmission potential, and the recovery rate [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. It is also evident that susceptibility to infection is not the same for all the susceptible but, among others, it is highly correlated with a subject&#x02019;s age due to age-related changes of the immune system [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. These observations together point towards some inherent biological processes where individual dynamics can help to predict population-level epidemics. Differences in the within-host infection profile as well as the susceptibility to infection complicate greatly epidemic models but at the same time underline their influential roles in determining epidemics features and intervention effects [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>].
<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic presentation of the within-host infections processes and their relation to transmission parameters. At the within-host level, viral replication and immune responses race with each other that eventually determines an individual infectivity, for example, his symptoms and possibly behaviours. At the between hosts level, infected individuals make contact(s) with susceptible individual(s) that eventually lead to a transmission, depending on both the infectivity of the infectious and the susceptibility of the susceptible. Noting that while the contact network can be fixed, the portion actively partake in epidemic spreading dynamically change over time [<xref ref-type="bibr" rid="CR75">75</xref>]</p></caption><graphic xlink:href="12889_2018_5709_Fig1_HTML" id="MO1"/></fig>
</p><p>The interplays between within-host infection and between hosts transmission led to arising attempts connecting the two levels [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>], but the approach is still at its infancy [<xref ref-type="bibr" rid="CR16">16</xref>]. On one hand, most of these models were conceptual and theoretical [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] or relied on assumptive and previously obtained parameter estimates [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. We propose that this limitation can be overcomed by using explicitly within-host infection model as a unit in epidemic simulations. This allows not only a high level of heterogeneity to be expressed, but also the study of stochasticity effects in epidemic spreading.</p><p>On the other hand, implementations of population level models were either a general representation using probabilistic assumptions [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] or a computationally demanding implementation of a particular population [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. These approaches, while able to recover valuable insights, may not be representative and accessible for another population of interest, because either none or large amount of data were needed. In this case, an implementation of an epidemic model with social mixing attributes, i.e., number of contacts per day and to whom the contact occurs, could be less computationaly intensive [<xref ref-type="bibr" rid="CR33">33</xref>], consistent across populations [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], and more representative for a realistic disease spreading process [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p><p>Improving understanding on EBOV transmission is crucial: EBOV can cause a large scale outbreak with a high fatality rate [<xref ref-type="bibr" rid="CR14">14</xref>] and it re-emerges continuously [<xref ref-type="bibr" rid="CR38">38</xref>]; as of May 2018, a total of 32 EBOV disease cases have been reported from Democratic Republic of the Congo, including 18 deaths [<xref ref-type="bibr" rid="CR38">38</xref>]. Based on our previous studies of the within-host EBOV infection [<xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>], we brought forward a within-host infection model to study the transmission fitness of EBOV at the population level. We built a network model based on social contact data [<xref ref-type="bibr" rid="CR34">34</xref>] and the respective epidemic simulation algorithm that embedded the within-host model into the contact network. Thus, this multiscale model was data-informed at each level of the epidemic process.</p><p>Our multi-scale model aimed to express the link between pathogen load and transmission potential of an infected host, the immune responses to the infection and vaccination, and the heterogeneity of the contact frequency distribution in a population. The parameters obtained from model simulations were compared to those estimated from population-level data and empirical observations. The results showed that within-host infection model reproduced estimates of the transmission parameters and allowed detailed evaluations of the effects of intervention timing on the course of the epidemic. Implementations of the network model from social contact data was straightforward and scalable for large simulations on high-performance computer clusters. In that capacity, epidemic assessments and preparations can be conducted quickly, ahead of time, and with high-resolution requirements.</p></sec><sec id="Sec2"><title>Methods</title><p>In an EBOV-infected subject, the immune system components dynamically evolve in response to the virus replication dynamic [<xref ref-type="bibr" rid="CR42">42</xref>]. As a result, a series of events is triggered determining the infection outcomes such as infectious status, symptoms, recovery, or death [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. In this paper, the EBOV replication dynamic within a host was used to infer its transmission parameters.</p><sec id="Sec3"><title>Within-host model</title><p>Using virus dynamics and the immune response data within a host, mathematical relations can be defined to test hypothesized infection mechanisms [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. In this context, non-human primates (NHPs) are the standard animal model for developing EBOV&#x02019;s therapeutics and vaccines in humans [<xref ref-type="bibr" rid="CR46">46</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref>]. Epidemiological and pharmacological studies reported that a viral load level higher than 10<sup>6</sup> copies/mL [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>] was associated with a higher mortality rate, whereas observations based on experimental data in NHPs showed that a viral load level higher than 10<sup>6</sup> TCID<sub>50</sub> was fatal [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Here the viral load dynamics were simulated based on a model as follows [<xref ref-type="bibr" rid="CR41">41</xref>]: 
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document} $$ \frac{dV}{dt} = r_{V} V\left(1-\frac{V}{K_{V}}\right) \left(\frac{V}{I_{n}+V}\right) \left(1 - \frac{{Ab}}{K_{Ab}}\right)  $$ \end{document}</tex-math><mml:math id="M2"><mml:mfrac><mml:mrow><mml:mtext mathvariant="italic">dV</mml:mtext></mml:mrow><mml:mrow><mml:mtext mathvariant="italic">dt</mml:mtext></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi></mml:mrow></mml:msub><mml:mi>V</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>V</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:mtext mathvariant="italic">Ab</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext mathvariant="italic">Ab</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="12889_2018_5709_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p><p>where <italic>r</italic><sub><italic>V</italic></sub>,<italic>K</italic><sub><italic>V</italic></sub>, and <italic>I</italic><sub><italic>n</italic></sub> denote the viral replication rate, the carrying capacity of the infected host, and a threshold expressing a lag-phase of viral replication. In particular, a logistic growth was assumed for EBOV, with a short delay when the virus level was low. The parameter <italic>K</italic><sub><italic>Ab</italic></sub> represents the strength of the immune system at which the antibody titre (<italic>Ab</italic>) completely inhibits the viral net growth rate [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], i.e., it was assumed that the higher antibody level required to inhibit the viral replication the weaker the immune strength. An antibody titre level of 10<sup>4</sup> appeared to be protective in NHPs and it required approximately one week after vaccination to reach this threshold [<xref ref-type="bibr" rid="CR44">44</xref>]. The model parameters were obtained previously [<xref ref-type="bibr" rid="CR41">41</xref>] using two experimental datasets on NHPs [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. The antibody dynamic (<italic>A</italic><italic>b</italic>) was also fitted in [<xref ref-type="bibr" rid="CR41">41</xref>] to the data of NHPs vaccinated with a recombinant vesicular stomatitis virus vaccine (rVSV-EBOV) [<xref ref-type="bibr" rid="CR44">44</xref>]. This vaccine had shown a high efficacy in human [<xref ref-type="bibr" rid="CR48">48</xref>]. Details of model fitting, data, and the parameter set can be found in [<xref ref-type="bibr" rid="CR41">41</xref>] and &#x0201c;Availability of data and materials&#x0201d; section.</p></sec><sec id="Sec4"><title>Simulated subject-specific infection course</title><p>To simulate subject-specific infection course, the antibody response strength <italic>K</italic><sub><italic>Ab</italic></sub> was varied from a normal level of approximately 10<sup>2.5</sup> [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] to the highest observed level of 10<sup>4.5</sup> [<xref ref-type="bibr" rid="CR44">44</xref>]. This parameter was assumed to follow a U-shaped function of an individual&#x02019;s age, where infants and elderly have a higher susceptibility ([<xref ref-type="bibr" rid="CR19">19</xref>], Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) (the extracted function is presented in &#x0201c;Availability of data and materials&#x0201d; section). As the infective dose can alter the course of infection [<xref ref-type="bibr" rid="CR51">51</xref>], the initial condition <italic>V</italic>(0) of the model Eq. <xref rid="Equ1" ref-type="">1</xref> was varied depending on from whom a subject acquired the infection, i.e., the infection dose was assumed as equal to the lethal dose (<italic>V</italic><sub><italic>c</italic></sub>=10<sup>0.15</sup> [<xref ref-type="bibr" rid="CR41">41</xref>]) times the transmission potential of a subject transmitting the infection. Here we assumed a direct relation between the transmission potential and the viral load at the time of infection [<xref ref-type="bibr" rid="CR16">16</xref>], i.e., the transmission potential <italic>p</italic><sub>Trans</sub>(<italic>t</italic>)=<italic>V</italic>(<italic>t</italic>)/<italic>K</italic><sub><italic>V</italic></sub>. Note that <italic>p</italic><sub>Trans</sub>(<italic>t</italic>)=1 does not guarantee a successful transmission, but it was considered collectively with its contact&#x02019;s susceptibility and with the existence of such a contact&#x02019;s (details in &#x0201c;Availability of data and materials&#x0201d; section).</p></sec><sec id="Sec5"><title>Infection outcomes definitions</title><p>Empirical observations from EBOV infected human and NHPs showed that the time from symptom onset to death was approximately one week [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Based on this, we used the total area under the viral load curve (AUC) seven days post-infection obtained from the subjects that died as a threshold above which the infection is lethal, i.e., <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\text {AUC}_{7} = \int _{0}^{7} V(t)dt$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mtext>AUC</mml:mtext></mml:mrow><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mrow><mml:mo>&#x0222b;</mml:mo></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:munderover><mml:mi>V</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mtext mathvariant="italic">dt</mml:mtext></mml:math><inline-graphic xlink:href="12889_2018_5709_Article_IEq1.gif"/></alternatives></inline-formula>. Otherwise, infected subjects were assumed to have recovered once the viral load was no longer detectable (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Depending on the infective dose and the adaptive immune response strength, the infection model manifests different viral dynamics and consequently the infection outcomes. Based on that, we defined the transmission parameters as in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>A-C (detailed implementations can be seen in &#x0201c;Availability of data and materials&#x0201d; section).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Simulated infection course using within-host infection dynamics. The viral replication, the antibody dynamics, and their interaction were modelled to define epidemiological parameters. It is assumed that when the EBOV-specific antibody concentration reaches a certain threshold, it can inhibit the viral replication [<xref ref-type="bibr" rid="CR76">76</xref>]. The total viral load under the curve (AUC) in lethal cases is used to define infection outcomes [<xref ref-type="bibr" rid="CR77">77</xref>]</p></caption><graphic xlink:href="12889_2018_5709_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Definitions of transmission parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Measure</th><th align="left">Definition</th></tr></thead><tbody><tr><td align="left">A</td><td align="justify">Incubation period</td><td align="justify">the interval between exposure to a pathogen and initial occurrence of symptoms [<xref ref-type="bibr" rid="CR79">79</xref>] was defined as from the infection time to the first time the viral load crosses over the detectable threshold (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</td></tr><tr><td align="left">B</td><td align="justify">Time from symptom onset to recovery [<xref ref-type="bibr" rid="CR79">79</xref>]</td><td align="justify">defined as the interval between the first day of detectable viral load and the first day the viral load becomes undetectable (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</td></tr><tr><td align="left">C</td><td align="justify">Time from symptom onset to death [<xref ref-type="bibr" rid="CR79">79</xref>]</td><td align="justify">defined as the interval between the first day with detectable viral load and the day the area under the viral load curve (AUC) crosses the reference threshold <italic>A</italic><italic>U</italic><italic>C</italic><sub>7</sub> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</td></tr><tr><td align="left">D</td><td align="justify">Basic reproductive number (R0)</td><td align="justify">calculated based on the network of infected subjects at the end of an epidemic in an initially susceptible population. In a network model, this equals the mean degree distribution of the infected network, considering a directed network without loops (e.g., Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The R0 by age-group was also calculated in the same fashion based on the assigned age-attribute. In epidemics with intervention or when the population is not fully susceptible, the R0 is called the <italic>effective reproduction number</italic> (Re).</td></tr><tr><td align="left">E</td><td align="justify">Final infected fraction</td><td align="justify">the proportion of infected nodes at the end of an epidemic simulation.</td></tr><tr><td align="left">F</td><td align="justify">Case-fatality rate</td><td align="justify">the proportion of nodes who died as a result of EBOV infection counted at the end of an epidemic simulation.</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec6"><title>Network model</title><p>The European&#x02019;s contact patterns survey data [<xref ref-type="bibr" rid="CR34">34</xref>] were used to generate a network model reflecting the number of contacts and the mixing patterns among age-groups. This dataset is currently the largest collection available on human contact patterns; moreover, a similar pattern has also been observed outside Europe [<xref ref-type="bibr" rid="CR35">35</xref>]. To make the contact pattern more specific to an EBOV-affected population, the age distribution of Freetown city in Sierra Leon [<xref ref-type="bibr" rid="CR53">53</xref>] was used to weight the contact pattern towards this area. In particular, while the contact frequency and pattern remain the same, these data were imposed on a network that has more young and less elderly subjects. A detailed description of the network implementation can be found in Availability of data and materials.</p><p>Because EBOV spreads through direct contacts with infectious subjects [<xref ref-type="bibr" rid="CR51">51</xref>], and the highest risk of infection is contacting with blood, faeces, and vomit [<xref ref-type="bibr" rid="CR54">54</xref>], we used only the data of physical contacts and excluded those contacts with a duration of less than five minutes. In the 2014 EBOV epidemic, an important transmission route was through contacting with the deceased who had not been buried [<xref ref-type="bibr" rid="CR2">2</xref>]. To account for this we considered deceased EBOV-infected subjects as infectious until they were buried. During the 2015 EBOV epidemic, the time from death to burial was from one to two days on average, but it can be a week [<xref ref-type="bibr" rid="CR55">55</xref>]. This information was used to formulate a truncated normal distribution for the time from death to burial, i.e., the distribution was truncated at zero and seven and had unit mean and variance (detailed implementations can be seen in Availability of data and materials).</p></sec><sec id="Sec7"><title>Transmission outcomes definitions</title><p>To obtain EBOV&#x02019;s epidemic metrics, the within-host infection model was embedded into the network model. Simulations of EBOV epidemic are detailed in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. In short, a network of ten thousand nodes was generated. Scenarios in which the population was randomly vaccinated during one-week vaccination program were tested and compared to a control simulation without vaccination. To isolate the effect of vaccination, we assumed that no other interventions were in place, e.g., no treatments were provided and no quarantine or isolation programs occurred. For each scenario, one thousand simulations were performed, each of which started with a single random index case. Each time when a contact occurred, the viral load at that time point was extracted to determine the transmission potential. Next, the susceptibility of the contact persons was computed as a function of their age [<xref ref-type="bibr" rid="CR19">19</xref>]. A Bernoulli trial was then used to determine if the contact results in an infection given the overall transmission probability. If the transmission succeeded, for the newly infected subject his/her own infection profile was computed. Based on simulation outputs, the epidemic outcomes were determined as in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>D-F (detailed implementations can be seen in Availability of data and materials).
<fig id="Fig3"><label>Fig. 3</label><caption><p>EBOV epidemic simulation process</p></caption><graphic xlink:href="12889_2018_5709_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec8"><title>Potential weaknesses and remedial approaches</title><p>The following assumptions were used given the lack of specific experimental data, but further efforts to produce the data can be done to address the issues listed here: 
<list list-type="simple"><list-item><label>(i)</label><p>Secondary antibody responses were assumed to be similar to primary responses. This underestimates the effect of vaccination strategies conducted before an epidemic. Experimental studies on secondary immune responses to EBOV infection are needed, especially those with a longer follow-up period.</p></list-item><list-item><label>(ii)</label><p>The transmission potential was assumed as directly related to viral load. While this is reasonable, non-linear relationships might exist [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Dedicated animal experiments to define the exact relationship between the viral load and the ability to transmit the virus are needed.</p></list-item><list-item><label>(iii)</label><p>The contact pattern was assumed similar for Ebola affected regions as in European countries. Although the contact patterns seemed similar across countries [<xref ref-type="bibr" rid="CR34">34</xref>], a more sociable population would have higher contact rate and thus increase R0. As collecting this data for all countries can be laborious, simulation studies addressing the effect of contact patterns on the connectivity in network models are needed.</p></list-item><list-item><label>(iv)</label><p>Infection status was assumed to have no influence on the network structure, except that those buried were removed from the network. This could overestimate R0 [<xref ref-type="bibr" rid="CR56">56</xref>]. Taking people&#x02019;s behaviour changes into epidemic modelling remains a grand challenge [<xref ref-type="bibr" rid="CR56">56</xref>].</p></list-item><list-item><label>(v)</label><p>Susceptibility to EBOV infection was assumed similar to a general viral infection disease. Studies on susceptibility functions are lacking and require more attention of the infection research community.</p></list-item></list></p></sec><sec id="Sec9"><title>Computational implementation</title><p>The simulations were written in vectorized R language [<xref ref-type="bibr" rid="CR57">57</xref>]. Ordinary differential equations (ODEs) were solved with deSolve package [<xref ref-type="bibr" rid="CR58">58</xref>]. The network was generated as an adjacency matrix and was visualized with the package igraph [<xref ref-type="bibr" rid="CR59">59</xref>]. Computations of infection dynamics of the newly infected nodes were done during the epidemic simulation after obtaining its infective dose and immunization status. For nodes with identical conditions, their infection courses were copied instead of recomputing the ODEs for speed (Availability of data and materials). Repeated runs of epidemic simulations to obtain uncertainty estimates were done on computer clusters of the Center for Scientific Computing (CSC) of the Goethe University Frankfurt. Distribution of computation resources was sent from within R to SLURM Workload Manager.</p></sec></sec><sec id="Sec10" sec-type="results"><title>Results</title><sec id="Sec11"><title>Basic transmission characteristics</title><p>Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> shows that the within-host infection model captured well the population-level transmission parameters. The results suggest that in contrary to using outbreak data, employing within-host infection model can provide this information prior to outbreaks, and even for a scenario where a pathogen <italic>X</italic> has never caused an epidemic before [<xref ref-type="bibr" rid="CR60">60</xref>].
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Simulated population-level transmission parameters based on within-host infection model</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="2">Range and medians (in days)</th></tr><tr><th align="left">Parameter</th><th align="left">Simulated</th><th align="left">Literature</th></tr></thead><tbody><tr><td align="left">Incubation period</td><td align="left">2.6&#x02013;12.4 (3.8)</td><td align="left">3.35&#x02013;12.7 (7) [<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td align="left">Time from symptom onset to recovery</td><td align="left">6.9&#x02013;17.6 (9.7)</td><td align="left">2&#x02013;26 (10) [<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td align="left">Time from symptom onset to death</td><td align="left">8.1&#x02013;15.1 (9)</td><td align="left">3&#x02013;21 (9&#x02013;10) [<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec12"><title>The network model</title><p>Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows an example of the generated networks and its required data. In particular, given a network of size <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$N \in \mathbb {N}$\end{document}</tex-math><mml:math id="M6"><mml:mi>N</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>&#x02115;</mml:mi></mml:math><inline-graphic xlink:href="12889_2018_5709_Article_IEq2.gif"/></alternatives></inline-formula>, each node was assigned an age such that the network&#x02019;s age-distribution resembled that of the target population. Subsequently, nodes were assigned a number of contacts per day following a defined contact distribution of interest. Finally, the algorithm visited each node to generate the defined number of contacts, not at random but following a defined contact matrix. The network was returned as an adjacent matrix that is compatible to available network analyses algorithms, e.g., igraph, graph-tool [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Storing data as a sparse matrix, a regular installation of R could generate reliably networks of 10-20 thousand nodes with the generation time 6-10 minutes on a single thread Intel Core i7, 8GB RAM. Note that R theoretically can only handle a maximum square matrix &#x02248;44721 rows and columns.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Required data and an example of an age-structure network model. (<bold>a</bold>) Generated network of one hundred individuals that mimics distribution of physical contact, contact matrix, and population age structure. The node&#x02019;s size reflects its number of contacts. Nodes in the same age-group have the same colour; (<bold>b</bold>) Distribution of number of physical contacts shows a majority of individuals have a few physical contact per day [<xref ref-type="bibr" rid="CR34">34</xref>]; (<bold>c</bold>) A heat map of contact matrix shows higher contact frequencies in darker shades. The matrix reflects the assortative pattern of human contacts, that is people contact mainly with their peers, follow by their children or parents. The age-group with the highest contacts are teenagers and young adults [<xref ref-type="bibr" rid="CR34">34</xref>]; (<bold>d</bold>) Reconstructed age-structure of Sierra Leon population based on Statistics Sierra Leone and ICF International data [<xref ref-type="bibr" rid="CR53">53</xref>]</p></caption><graphic xlink:href="12889_2018_5709_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec13"><title>Calculating basic reproductive number (R0)</title><p>After each simulation, the uninfected nodes were removed from the initial network. Then the basic reproduction number was calculated as the average network degree, considering the network as a directed and without loop network (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>-Left). Simulation results showed that the overall estimate of R0 was 1.43 (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>-Right). However, the estimates differed across age-groups with the highest of 4.7 for the group of 10-14 years of age. Intuitively, the age-groups with a higher contact rate had also a higher R0. Simulations of epidemics with varied intervention strategies showed that Re can be reduced below unity if a vaccination program with 85% coverage was deployed at the time as far as five months before the introduction of the index case (time zero) or as late as one week after that (Additional file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). This coverage threshold was tested as it is the highest vaccine coverage currently achieved worldwide for some diseases, e.g., Hepatitis B, measles, and polio [<xref ref-type="bibr" rid="CR63">63</xref>]. Late initiations of a similar intervention from one to five months after the time zero gradually shifted the Re to the outbreak domain.
<fig id="Fig5"><label>Fig. 5</label><caption><p>Left. Three examples of infected networks. The three networks were randomly chosen from the simulated epidemics. Uninfected nodes were removed and the network is plotted. Based on these, the R0 was calculated based on the edges assuming a directed network, i.e., each edge counted in only one direction. Right. Estimates of the basic reproductive number without any intervention, overall and by age-groups. Simulations of a network of size ten thousand during a period of one year. One thousand simulations were run, each time with a random index case. At the end of each simulation, networks of infected nodes were extracted to compute the average number of secondary infections</p></caption><graphic xlink:href="12889_2018_5709_Fig5_HTML" id="MO5"/></fig>
</p><p>A lower vaccination coverage of 33%, while substantially reduced the epidemic size, still posed a potential of a large outbreak regardless the timing of vaccination program (Additional file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). This coverage was tested as it is a theoretically protective threshold in stochastic and heterogeneous mixing models, i.e., 1-1/R0 [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Note that the tested time window of five months before the appearance of the index case was chosen based on the windows of opportunity for EBOV vaccination [<xref ref-type="bibr" rid="CR41">41</xref>]. As of now, no detailed data are available on the secondary antibody responses to EBOV; it was therefore assumed that secondary responses are similar to the primary responses.</p></sec><sec id="Sec14"><title>Case-fatality rate</title><p>Simulations showed that the case-fatality rate in the absence of intervention was about 91% (Additional file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Figure S2), which falls within the range of literature estimates of 0.4 to 0.91 [<xref ref-type="bibr" rid="CR79">79</xref>]. Note that the simulations assumed worst case scenarios where no other inverventions were done except the vaccination. Furthermore, simulation results showed that all the intervention strategies mentioned previously reduced the case-fatality rate. These results highlighted a benefit of vaccination programs even if they were late: reducing the disease severity in newly infected subjects after the introduction of the vaccination program. As such, relying on R0 as the solely indicator for evaluating intervention programs would overlook this life-saving aspect.</p></sec><sec id="Sec15"><title>Epidemic final size</title><p>Theoretical analyses of stochastic epidemic models showed that when R0 is larger than unity, the final size of an epidemic converges to a bimodal distribution: either the epidemic dies out with a small number of infected cases or the epidemic takes off to a normal distribution with a high number of cases [<xref ref-type="bibr" rid="CR7">7</xref>]. Our simulation results recreated this epidemic behavior (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Without intervention, EBOV had approximately 50% probability to infect more than half the population. The introduction of vaccination programs at the two previously mentioned coverages and at any vaccination time points under assessment scaled down the epidemic size (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). The earlier the vaccination programs were deployed, the closer the epidemics size distribution resemble to a uni-modal distribution centered at a low infected fraction. The high vaccine coverage strategy effectively eliminated the possibility of having a major outbreak infecting a large proportion of the population. This was achieved when the vaccination programs were deployed at any time point from one week to five months before time zero.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Distribution of the final infected fraction in different timing and coverage of vaccination strategies. A synthetic population of ten thousand individuals was generated. One thousand simulations were run to simulate the epidemic in the time course of one year. Each time, one individual was chosen randomly as the index case. Circles, diamonds, and connected lines are median. Filled areas are the corresponding non-parametric densities estimates [<xref ref-type="bibr" rid="CR78">78</xref>]. Two median values are presented for multi-modal density estimates, determining by inflection points</p></caption><graphic xlink:href="12889_2018_5709_Fig6_HTML" id="MO6"/></fig>
</p><p>Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref> also shows that a random vaccination program covering 33% of the population one week before the time zero reduced the final size by more than 100 times compared to a no intervention scenario. However, the low coverage strategy still showed a small probability that the epidemic becomes major, whereas the high coverage strategies did not. Vaccination programs deployed during the epidemics also substantially reduced the epidemic&#x02019;s size: the vaccination program conducted one month after time zero still reduced the final size by more than ten times. Furthermore, these interventions were not only able to reduce the final size, but they could also increase the epidemics extinction probability (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).</p></sec></sec><sec id="Sec16" sec-type="discussion"><title>Discussion</title><p>In estimating parameters and designing prevention strategies for infectious diseases, it is important to take into account mechanisms underlying the heterogeneity in immune responses [<xref ref-type="bibr" rid="CR65">65</xref>] and in the population [<xref ref-type="bibr" rid="CR34">34</xref>]. This paper combined a within-host immunological model of Ebola virus (EBOV) infection and an age- and demographic-specfic contact network to study EBOV epidemic. The multi-scale model reproduced major characteristics of EBOV epidemics and allowed finer assessments of the timing of vaccination strategies.</p><p>Estimates of the EBOV&#x02019;s incubation period suggested a contact tracing period of three weeks for Ebola epidemics, matching the current WHO&#x02019;s recommendation of 21 days [<xref ref-type="bibr" rid="CR66">66</xref>]. Estimates of the delay distributions agreed with information that EBOV infected subjects can be infectious from day 3 up to three weeks post infection [<xref ref-type="bibr" rid="CR79">79</xref>]. Understanding of these delay distributions is critical in clinical and epidemiological perspectives [<xref ref-type="bibr" rid="CR67">67</xref>]. These distributions, however, are often only partially observed in practice: it is difficult to know the exact time of exposure to the pathogen or to have complete outbreak data [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. As such, parameter estimation of these distributions have been relied on testing and comparing distributional assumptions [<xref ref-type="bibr" rid="CR69">69</xref>]. The mechanistically generated transmission characteristics using virus dynamics remarkably resemble literature estimates. This suggests some inherent biological processes where individual dynamics accumulate to produce population-level epidemics. This approach is thus promising and practical given the accumulating experimental data on varieties of pathogens, such as a disease <italic>X</italic> [<xref ref-type="bibr" rid="CR60">60</xref>] that as yet unknown in epidemic contexts.</p><p>To determine infection outcomes, the threshold AUC<sub>7</sub> was chosen based on suggestions derived from empirical data in humans [<xref ref-type="bibr" rid="CR52">52</xref>] and non-human primates [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Simulations of the epidemics using this threshold reproduced estimate of EBOV case-fatality rate (Additional file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Figure S2), suggesting that the use of total viral load (AUC) as a criterion for determining infection outcomes is appropriate. It is worth noting that the calculated case fatality rate was based on the assumption of worst case scenarios where no treatments were provided. In practice there were medical approaches to reduce disease severity. Scientific literature has shown that for severe cases of EBOV infection (equivalent to unvaccinated subjects or those vaccinated too late in our model), supportive treatments increased substantially the survival chance [<xref ref-type="bibr" rid="CR70">70</xref>]. Although a more precise threshold criterion is desirable, it might not be feasible to obtain it in practice considering the inherent ethical reasons. Thus a similar criterion as used here could be considered when adapting this approach to other diseases, but ideally derived from dedicated experimental data.</p><p>Different classes of network models have been proposed, but they cannot reproduce properties observed in real world networks [<xref ref-type="bibr" rid="CR71">71</xref>]. In addition, choices of theoretical network structure used for simulation can alter epidemic outcomes [<xref ref-type="bibr" rid="CR30">30</xref>]. Thus, a network model built from empirical data would provide a more solid ground for epidemic simulations. Apart from mimicking the contact data properties, our network model can express age-related infection traits via the assigned age attribute. It was used in this paper to express individual differences in the susceptibility and immune response to viral infection&#x02014;the crucial elements in a realistic disease transmission. Although contact data might not be available for a certain target area, the assortative patterns of human contacts and the highly skewed distribution of the number of contacts might hold true across regions [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Thus, this paper presents a simple way to bring empirical contact data into epidemic modelling studies.</p><p>Our network model currently can only simulate epidemics in a population of size 10&#x02013;20 thousand. This is because of the limit in R with the theoretical maximum square matrix size of approximately 45000 [<xref ref-type="bibr" rid="CR57">57</xref>]. A more efficient storing of the network could extend the network size, such as a lazy evaluation used in igraph [<xref ref-type="bibr" rid="CR61">61</xref>]. However, it could be more realistic to have several communities amount to a large population size instead of a large single network. This can be implemented by generating different communities across computers and allow them to communicate, speeding also the computation processes [<xref ref-type="bibr" rid="CR72">72</xref>]. In this case, additional data are needed to model the communication among the communities, such as transportation network and immigration flow.</p><p>Regarding EBOV epidemics, previous R0 estimates based on epidemic data varied strongly, depending on model choices and assumptions [<xref ref-type="bibr" rid="CR79">79</xref>]. Our estimate of R0 was 1.4 which is within the range of the previous estimates, ranging from 1.2 to 2.6, with some exceptional estimates up to 4.7 and 8.3 [<xref ref-type="bibr" rid="CR79">79</xref>]. Notably, we showed that the estimates differed by age-groups with the highest of 4.7 for the group of 10&#x02013;14-years of age. Although these estimates depend on Sierra Leon&#x02019;s age-structure, the differences of R0 estimate stress the role of the age-structure and contact patterns in the estimation of R0, prompting that age-specific intervention strategies should be considered. The estimates by sub-groups also single out the effort required to control the epidemic [<xref ref-type="bibr" rid="CR73">73</xref>]. With the assumptions used in our models, targeting interventions to the group 5&#x02013;20-years of age would be the most effective strategy. Note that the differences of R0 by age-group also provide us an explanation of the wide variation of the previous estimates of R0 where different samples were used [<xref ref-type="bibr" rid="CR79">79</xref>]. As the R0 estimates were larger in sub-groups, our results confirmed that the critical vaccine coverage also needed to be larger to ensure eradication of the epidemic [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Using our approach, we have shown further that while a low coverage could not completely eradicate the epidemic, it could largely reduce both the size and severity of an epidemic&#x02014;which is worth pursuing in cases of lacking resources to reach an optimal threshold.</p></sec><sec id="Sec17" sec-type="conclusion"><title>Conclusion</title><p>Throughout this paper, we showed the possibilities to investigate practical and intriguing questions using a within-host viral dynamic model and an age-structured network model. The advantages of using explicitly within-host dynamics are the availability of experimental data, the possibility of conducting experiments to characterize transmission parameters, and the ability to provide high-resolution subject-specific responses to infection. The advantages of using an age-structured network model are its simple implementation, its representativeness for disease transmission, and the availability of the age-structured data. Therefore, immunological studies of infectious agents could be seamlessly integrated into studies of between hosts transmission, promoting evidence-based public health practices.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12889_2018_5709_MOESM1_ESM.pdf"><label>Additional file 1</label><caption><p><bold>Figure S1.</bold> Estimates of the reproductive number in different vaccination schemes. Simulations of a network of size ten thousand during a period of one year are performed. One thousand simulations were run, each time with a random index case. At the end of each simulation, the network of infected nodes was extracted to compute the average number of secondary infections. (PDF 27 kb)</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12889_2018_5709_MOESM2_ESM.pdf"><label>Additional file 2</label><caption><p><bold>Figure S2.</bold> Case-fatality rate in different vaccination schemes. Simulations of a network of size ten thousand during a period of one year are performed. One thousand simulations were run, each time with a random index case. At the end of each simulation, the network of infected nodes was extracted to compute the case-fatality rate. (PDF 28 kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AUC</term><def><p>Area under the curve</p></def></def-item><def-item><term>EBOV</term><def><p>Ebola virus</p></def></def-item><def-item><term>NHPs</term><def><p>Non-human primates</p></def></def-item><def-item><term>R0</term><def><p>Basic reproduction number</p></def></def-item><def-item><term>Re</term><def><p>Effective reproduction number</p></def></def-item><def-item><term>VSV</term><def><p>Vesicular stomatitis virus</p></def></def-item><def-item><term>WHO</term><def><p>World health organization</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s12889-018-5709-x) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><sec id="d29e1502"><title>Funding</title><p>This work was supported by the Alfons und Gertrud Kassel-Stiftung. VKN was supported by the Presidents Initiative and Networking Funds of the Helmholtz Association of German Research Centres (HGF) under contract number VH-GS-202. The funders have no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p></sec><sec id="d29e1507"><title>Availability of data and materials</title><p>All data generated or analysed during this study are included in this published article and its supplementary information files.</p><p><bold>Code and examples &#x02014; Generating age-specific contact network</bold> R code for generating an example contact network can be found at <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.5281/zenodo.1037264">http://doi.org/10.5281/zenodo.1037264</ext-link>.</p><p><bold>Code and examples &#x02014; Epidemic simulations</bold> R code for epidemic simulations can be found at 10.5281/zenodo.1045404.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>EAHV supervised the project. VKN designed the modelling and performed the simulations. VKN, EAHV and RM provided and analysed the data. VKN, EAHV and RM discussed and wrote the manuscript. All authors reviewed the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="d29e1536"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="d29e1541"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="d29e1546"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="d29e1551"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>B</given-names></name></person-group><article-title>The next epidemic&#x02013;lessons from Ebola</article-title><source>N Engl J Med</source><year>2015</year><volume>372</volume><issue>15</issue><fpage>1381</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1056/NEJMp1502918</pub-id><?supplied-pmid 25853741?><pub-id pub-id-type="pmid">25853741</pub-id></element-citation></ref><ref id="CR2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piot</surname><given-names>P</given-names></name></person-group><article-title>Public health: Beating Ebola</article-title><source>Nature</source><year>2016</year><volume>537</volume><issue>7621</issue><fpage>484</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/537484a</pub-id></element-citation></ref><ref id="CR3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lofgren</surname><given-names>ET</given-names></name><name><surname>Halloran</surname><given-names>ME</given-names></name><name><surname>Rivers</surname><given-names>CM</given-names></name><name><surname>Drake</surname><given-names>JM</given-names></name><name><surname>Porco</surname><given-names>TC</given-names></name><name><surname>Lewis</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Vespignani</surname><given-names>A</given-names></name><name><surname>Shaman</surname><given-names>J</given-names></name><name><surname>Eisenberg</surname><given-names>JN</given-names></name><name><surname>Eisenberg</surname><given-names>MC</given-names></name><name><surname>Marathe</surname><given-names>M</given-names></name><name><surname>Scarpino</surname><given-names>SV</given-names></name><name><surname>Alexander</surname><given-names>KA</given-names></name><name><surname>Meza</surname><given-names>R</given-names></name><name><surname>Ferrari</surname><given-names>MJ</given-names></name><name><surname>Hyman</surname><given-names>JM</given-names></name><name><surname>Meyers</surname><given-names>LA</given-names></name><name><surname>Eubank</surname><given-names>S</given-names></name></person-group><article-title>Opinion: Mathematical models: a key tool for outbreak response</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><issue>51</issue><fpage>18095</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.1421551111</pub-id><?supplied-pmid 25502594?><pub-id pub-id-type="pmid">25502594</pub-id></element-citation></ref><ref id="CR4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willem</surname><given-names>L</given-names></name><name><surname>Verelst</surname><given-names>F</given-names></name><name><surname>Bilcke</surname><given-names>J</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Beutels</surname><given-names>P</given-names></name></person-group><article-title>Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)</article-title><source>BMC Infect Dis</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>612</fpage><pub-id pub-id-type="doi">10.1186/s12879-017-2699-8</pub-id><?supplied-pmid 28893198?><pub-id pub-id-type="pmid">28893198</pub-id></element-citation></ref><ref id="CR5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>May</surname><given-names>RM</given-names></name></person-group><source>Infectious Diseases of Humans: Dynamics and Control</source><year>1992</year><publisher-loc>Oxford</publisher-loc><publisher-name>OUP Oxford</publisher-name></element-citation></ref><ref id="CR6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heesterbeek</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Andreasen</surname><given-names>V</given-names></name><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>De Angelis</surname><given-names>D</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name><name><surname>Eames</surname><given-names>KTD</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Frost</surname><given-names>SDW</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Hollingsworth</surname><given-names>TD</given-names></name><name><surname>House</surname><given-names>T</given-names></name><name><surname>Isham</surname><given-names>V</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Mollison</surname><given-names>D</given-names></name><name><surname>Pellis</surname><given-names>L</given-names></name><name><surname>Pulliam</surname><given-names>JRC</given-names></name><name><surname>Roberts</surname><given-names>MG</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name></person-group><article-title>Modeling infectious disease dynamics in the complex landscape of global health</article-title><source>Science</source><year>2015</year><volume>347</volume><issue>6227</issue><fpage>4339</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4339</pub-id></element-citation></ref><ref id="CR7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britton</surname><given-names>T</given-names></name></person-group><article-title>Stochastic epidemic models: A survey</article-title><source>Math Biosci</source><year>2010</year><volume>225</volume><issue>1</issue><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.mbs.2010.01.006</pub-id><?supplied-pmid 20102724?><pub-id pub-id-type="pmid">20102724</pub-id></element-citation></ref><ref id="CR8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Shkedy</surname><given-names>Z</given-names></name><name><surname>Aerts</surname><given-names>M</given-names></name><name><surname>Faes</surname><given-names>C</given-names></name><name><surname>Van Damme</surname><given-names>P</given-names></name><name><surname>Beutels</surname><given-names>P</given-names></name></person-group><source>Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: A Modern Statistical Perspective. Statistics for Biology and Health</source><year>2012</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomeroy</surname><given-names>LW</given-names></name><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>Tildesley</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>KIM</given-names></name><name><surname>Moritz</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>N</given-names></name><name><surname>Carpenter</surname><given-names>TE</given-names></name><name><surname>Garabed</surname><given-names>RB</given-names></name></person-group><article-title>Data-Driven Models of Foot-and-Mouth Disease Dynamics: A Review</article-title><source>Transboundary Emerg Dis</source><year>2017</year><volume>64</volume><issue>3</issue><fpage>716</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1111/tbed.12437</pub-id></element-citation></ref><ref id="CR10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merler</surname><given-names>S</given-names></name><name><surname>Ajelli</surname><given-names>M</given-names></name><name><surname>Fumanelli</surname><given-names>L</given-names></name><name><surname>Parlamento</surname><given-names>S</given-names></name><name><surname>Pastore Y Piontti</surname><given-names>A</given-names></name><name><surname>Dean</surname><given-names>NE</given-names></name><name><surname>Putoto</surname><given-names>G</given-names></name><name><surname>Carraro</surname><given-names>D</given-names></name><name><surname>Longini</surname><given-names>IM</given-names></name><name><surname>Halloran</surname><given-names>ME</given-names></name><name><surname>Vespignani</surname><given-names>A</given-names></name></person-group><article-title>Containing Ebola at the Source with Ring Vaccination</article-title><source>PLoS Negl Trop Dis</source><year>2016</year><volume>10</volume><issue>11</issue><fpage>0005093</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0005093</pub-id></element-citation></ref><ref id="CR11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukens</surname><given-names>S</given-names></name><name><surname>DePasse</surname><given-names>J</given-names></name><name><surname>Rosenfeld</surname><given-names>R</given-names></name><name><surname>Ghedin</surname><given-names>E</given-names></name><name><surname>Mochan</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>ST</given-names></name><name><surname>Grefenstette</surname><given-names>J</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name><name><surname>Swigon</surname><given-names>D</given-names></name><name><surname>Clermont</surname><given-names>G</given-names></name></person-group><article-title>A large-scale immuno-epidemiological simulation of influenza A epidemics</article-title><source>BMC Public Health</source><year>2014</year><volume>14</volume><fpage>1019</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-14-1019</pub-id><?supplied-pmid 25266818?><pub-id pub-id-type="pmid">25266818</pub-id></element-citation></ref><ref id="CR12"><label>12</label><mixed-citation publication-type="other">World Health Organization. Outbreak communication: Best practices for communicating with the public during an outbreak. Technical report.</mixed-citation></ref><ref id="CR13"><label>13</label><mixed-citation publication-type="other">Nguyen VK, Parra-Rojas C, Hernandez-Vargas EA. The 2017 plague outbreak in Madagascar: data descriptions and epidemic modelling. Epidemics. 2018. pii: S1755-4365(18)30007-0. 10.1016/j.epidem.2018.05.001.</mixed-citation></ref><ref id="CR14"><label>14</label><mixed-citation publication-type="other">World Health Organization. Ebola Situation Report - 7 January 2015 | Ebola. Technical report. <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/ebola/en/status-outbreak/situation-reports/ebola-situation-report-7-january-2015">http://apps.who.int/ebola/en/status-outbreak/situation-reports/ebola-situation-report-7-january-2015</ext-link>.</mixed-citation></ref><ref id="CR15"><label>15</label><mixed-citation publication-type="other">Lloyd-Smith JO, Funk S, McLean AR, Riley S, Wood JLN. Nine challenges in modelling the emergence of novel pathogens. Epidemics. 2014:1&#x02013;5. 10.1016/j.epidem.2014.09.002.</mixed-citation></ref><ref id="CR16"><label>16</label><mixed-citation publication-type="other">Handel A, Rohani P. Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675).</mixed-citation></ref><ref id="CR17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizon</surname><given-names>S</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name><name><surname>Regoes</surname><given-names>RR</given-names></name></person-group><article-title>Epidemiological and clinical consequences of within-host evolution</article-title><source>Trends Microbiol</source><year>2011</year><volume>19</volume><issue>1</issue><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2010.09.005</pub-id><?supplied-pmid 21055948?><pub-id pub-id-type="pmid">21055948</pub-id></element-citation></ref><ref id="CR18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Chio</surname><given-names>CP</given-names></name><name><surname>Jou</surname><given-names>LJ</given-names></name><name><surname>Liao</surname><given-names>CM</given-names></name></person-group><article-title>Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection</article-title><source>Indoor Air</source><year>2009</year><volume>19</volume><issue>5</issue><fpage>401</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0668.2009.00603.x</pub-id><?supplied-pmid 19659895?><pub-id pub-id-type="pmid">19659895</pub-id></element-citation></ref><ref id="CR19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farber</surname><given-names>DL</given-names></name><name><surname>Yudanin</surname><given-names>NA</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name></person-group><article-title>Human memory T cells: generation, compartmentalization and homeostasis</article-title><source>Nat Rev Immunol</source><year>2014</year><volume>14</volume><issue>1</issue><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nri3567</pub-id><?supplied-pmid 24336101?><pub-id pub-id-type="pmid">24336101</pub-id></element-citation></ref><ref id="CR20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name><name><surname>Wilk</surname><given-names>E</given-names></name><name><surname>Canini</surname><given-names>L</given-names></name><name><surname>Toapanta</surname><given-names>FR</given-names></name><name><surname>Binder</surname><given-names>SC</given-names></name><name><surname>Uvarovskii</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>TM</given-names></name><name><surname>Guzman</surname><given-names>CA</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name><name><surname>Meyer-Hermann</surname><given-names>M</given-names></name></person-group><article-title>Effects of aging on influenza virus infection dynamics</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><issue>8</issue><fpage>4123</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1128/JVI.03644-13</pub-id><?supplied-pmid 24478442?><pub-id pub-id-type="pmid">24478442</pub-id></element-citation></ref><ref id="CR21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozhnova</surname><given-names>G</given-names></name><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Characterizing the dynamics of rubella relative to measles: the role of stochasticity</article-title><source>J R Soc Interface</source><year>2013</year><volume>10</volume><issue>88</issue><fpage>20130643</fpage><lpage>20130643</lpage><pub-id pub-id-type="doi">10.1098/rsif.2013.0643</pub-id><?supplied-pmid 24026472?><pub-id pub-id-type="pmid">24026472</pub-id></element-citation></ref><ref id="CR22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caudron</surname><given-names>Q</given-names></name><name><surname>Mahmud</surname><given-names>AS</given-names></name><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Gottfrethsson</surname><given-names>M</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name><name><surname>Cliff</surname><given-names>AD</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Predictability in a highly stochastic system: final size of measles epidemics in small populations</article-title><source>J R Soc Interface</source><year>2014</year><volume>12</volume><issue>102</issue><fpage>20141125</fpage><pub-id pub-id-type="doi">10.1098/rsif.2014.1125</pub-id></element-citation></ref><ref id="CR23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkenstadt</surname><given-names>BF</given-names></name></person-group><article-title>A stochastic model for extinction and recurrence of epidemics: estimation and inference for measles outbreaks</article-title><source>Biostatistics</source><year>2002</year><volume>3</volume><issue>4</issue><fpage>493</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/3.4.493</pub-id><?supplied-pmid 12933594?><pub-id pub-id-type="pmid">12933594</pub-id></element-citation></ref><ref id="CR24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murillo</surname><given-names>LN</given-names></name><name><surname>Murillo</surname><given-names>MS</given-names></name><name><surname>Perelson</surname><given-names>AS</given-names></name></person-group><article-title>Towards multiscale modeling of influenza infection</article-title><source>J Theor Biol</source><year>2013</year><volume>332</volume><fpage>267</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2013.03.024</pub-id><?supplied-pmid 23608630?><pub-id pub-id-type="pmid">23608630</pub-id></element-citation></ref><ref id="CR25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>T</given-names></name><name><surname>Alizon</surname><given-names>S</given-names></name><name><surname>Mideo</surname><given-names>N</given-names></name></person-group><article-title>Bridging scales in the evolution of infectious disease life histories: theory</article-title><source>Evolution</source><year>2011</year><volume>65</volume><issue>12</issue><fpage>3448</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1111/j.1558-5646.2011.01394.x</pub-id><?supplied-pmid 22133217?><pub-id pub-id-type="pmid">22133217</pub-id></element-citation></ref><ref id="CR26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longini</surname><given-names>IM</given-names></name><name><surname>Nizam</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Ungchusak</surname><given-names>K</given-names></name><name><surname>Hanshaoworakul</surname><given-names>W</given-names></name><name><surname>Cummings</surname><given-names>DA</given-names></name><name><surname>Halloran</surname><given-names>ME</given-names></name></person-group><article-title>Containing pandemic influenza at the source</article-title><source>Science</source><year>2005</year><volume>309</volume><issue>5737</issue><fpage>1083</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.1115717</pub-id><?supplied-pmid 16079251?><pub-id pub-id-type="pmid">16079251</pub-id></element-citation></ref><ref id="CR27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cen</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Emerging disease dynamics in a model coupling within-host and between-host systems</article-title><source>J Theor Biol</source><year>2014</year><volume>361</volume><fpage>141</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2014.07.030</pub-id><?supplied-pmid 25093825?><pub-id pub-id-type="pmid">25093825</pub-id></element-citation></ref><ref id="CR28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almocera</surname><given-names>AES</given-names></name><name><surname>Nguyen</surname><given-names>VK</given-names></name><name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name></person-group><article-title>Multiscale model within-host and between-host for viral infectious diseases</article-title><source>J Math Biol</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>23</lpage></element-citation></ref><ref id="CR29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BY</given-names></name><name><surname>Brown</surname><given-names>ST</given-names></name><name><surname>Korch</surname><given-names>G</given-names></name><name><surname>Cooley</surname><given-names>PC</given-names></name><name><surname>Zimmerman</surname><given-names>RK</given-names></name><name><surname>Wheaton</surname><given-names>WD</given-names></name><name><surname>Zimmer</surname><given-names>SM</given-names></name><name><surname>Grefenstette</surname><given-names>JJ</given-names></name><name><surname>Bailey</surname><given-names>RR</given-names></name><name><surname>Assi</surname><given-names>T-M</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name></person-group><article-title>A Computer Simulation of Vaccine Prioritization, Allocation, and Rationing During the 2009 H1N1 Influenza Pandemic</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><issue>31</issue><fpage>4875</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.05.002</pub-id><?supplied-pmid 20483192?><pub-id pub-id-type="pmid">20483192</pub-id></element-citation></ref><ref id="CR30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmandad</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Tebbens</surname><given-names>RJD</given-names></name><name><surname>Thompson</surname><given-names>KM</given-names></name></person-group><article-title>Development of an individual-based model for polioviruses: implications of the selection of network type and outcome metrics</article-title><source>Epidemiol Infect</source><year>2011</year><volume>139</volume><issue>6</issue><fpage>836</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1017/S0950268810001676</pub-id><?supplied-pmid 20619075?><pub-id pub-id-type="pmid">20619075</pub-id></element-citation></ref><ref id="CR31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastor-Satorras</surname><given-names>R</given-names></name><name><surname>Vespignani</surname><given-names>A</given-names></name></person-group><article-title>Epidemic spreading in scale-free networks</article-title><source>Phys Rev Let</source><year>2001</year><volume>86</volume><fpage>3200</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.86.3200</pub-id><pub-id pub-id-type="pmid">11290142</pub-id></element-citation></ref><ref id="CR32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>ST</given-names></name><name><surname>Tai</surname><given-names>JH</given-names></name><name><surname>Bailey</surname><given-names>RR</given-names></name><name><surname>Cooley</surname><given-names>PC</given-names></name><name><surname>Wheaton</surname><given-names>WD</given-names></name><name><surname>Potter</surname><given-names>MA</given-names></name><name><surname>Voorhees</surname><given-names>RE</given-names></name><name><surname>LeJeune</surname><given-names>M</given-names></name><name><surname>Grefenstette</surname><given-names>JJ</given-names></name><name><surname>Burke</surname><given-names>DS</given-names></name><name><surname>McGlone</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>BY</given-names></name></person-group><article-title>Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania</article-title><source>BMC Public Health</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>353</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-11-353</pub-id><?supplied-pmid 21599920?><pub-id pub-id-type="pmid">21599920</pub-id></element-citation></ref><ref id="CR33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eames</surname><given-names>KTD</given-names></name><name><surname>Read</surname><given-names>JM</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name></person-group><article-title>Epidemic prediction and control in weighted networks</article-title><source>Epidemics</source><year>2009</year><volume>1</volume><issue>1</issue><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2008.12.001</pub-id><?supplied-pmid 21352752?><pub-id pub-id-type="pmid">21352752</pub-id></element-citation></ref><ref id="CR34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossong</surname><given-names>J</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Jit</surname><given-names>M</given-names></name><name><surname>Beutels</surname><given-names>P</given-names></name><name><surname>Auranen</surname><given-names>K</given-names></name><name><surname>Mikolajczyk</surname><given-names>R</given-names></name><name><surname>Massari</surname><given-names>M</given-names></name><name><surname>Salmaso</surname><given-names>S</given-names></name><name><surname>Tomba</surname><given-names>GS</given-names></name><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Heijne</surname><given-names>J</given-names></name><name><surname>Sadkowska-Todys</surname><given-names>M</given-names></name><name><surname>Rosinska</surname><given-names>M</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name></person-group><article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title><source>PLoS Med</source><year>2008</year><volume>5</volume><issue>3</issue><fpage>74</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0050074</pub-id></element-citation></ref><ref id="CR35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horby</surname><given-names>P</given-names></name><name><surname>Pham</surname><given-names>QT</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Le</surname><given-names>QM</given-names></name><name><surname>Dang</surname><given-names>DT</given-names></name><name><surname>Nguyen</surname><given-names>ML</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name><name><surname>Alexander</surname><given-names>N</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Tran</surname><given-names>ND</given-names></name><name><surname>Fox</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name></person-group><article-title>Social contact patterns in Vietnam and implications for the control of infectious diseases</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><issue>2</issue><fpage>16965</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0016965</pub-id></element-citation></ref><ref id="CR36"><label>36</label><mixed-citation publication-type="other">Pastor-satorras R, Castellano C, Mieghem PV, Vespignani A. Epidemic processes in complex networks. 2015:1&#x02013;62. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/arXiv:1408.2701v2">arXiv:1408.2701v2</ext-link>.</mixed-citation></ref><ref id="CR37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellis</surname><given-names>L</given-names></name><name><surname>Ball</surname><given-names>F</given-names></name><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>Eames</surname><given-names>K</given-names></name><name><surname>House</surname><given-names>T</given-names></name><name><surname>Isham</surname><given-names>V</given-names></name><name><surname>Trapman</surname><given-names>P</given-names></name></person-group><article-title>Eight challenges for network epidemic models</article-title><source>Epidemics</source><year>2015</year><volume>10</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2014.07.003</pub-id><?supplied-pmid 25843385?><pub-id pub-id-type="pmid">25843385</pub-id></element-citation></ref><ref id="CR38"><label>38</label><mixed-citation publication-type="other">World Health Organization. Ebola Virus Disease &#x02013; Democratic Republic of the Congo. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/10-may-2018-ebola-drc/en/">http://www.who.int/csr/don/10-may-2018-ebola-drc/en/</ext-link>.</mixed-citation></ref><ref id="CR39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>VK</given-names></name><name><surname>Binder</surname><given-names>SC</given-names></name><name><surname>Boianelli</surname><given-names>A</given-names></name><name><surname>Meyer-Hermann</surname><given-names>M</given-names></name><name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name></person-group><article-title>Ebola virus infection modeling and identifiability problems</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>7590</fpage></element-citation></ref><ref id="CR40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>VK</given-names></name><name><surname>Klawonn</surname><given-names>F</given-names></name><name><surname>Mikolajczyk</surname><given-names>R</given-names></name><name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name></person-group><article-title>Analysis of Practical Identifiability of a Viral Infection Model</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>12</issue><fpage>0167568</fpage></element-citation></ref><ref id="CR41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>VK</given-names></name><name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name></person-group><article-title>Windows of opportunity for Ebola virus infection treatment and vaccination</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>8975</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-08884-0</pub-id><?supplied-pmid 28827623?><pub-id pub-id-type="pmid">28827623</pub-id></element-citation></ref><ref id="CR42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prescott</surname><given-names>JB</given-names></name><name><surname>Marzi</surname><given-names>A</given-names></name><name><surname>Safronetz</surname><given-names>D</given-names></name><name><surname>Robertson</surname><given-names>SJ</given-names></name><name><surname>Feldmann</surname><given-names>H</given-names></name><name><surname>Best</surname><given-names>SM</given-names></name></person-group><article-title>Immunobiology of Ebola and Lassa virus infections</article-title><source>Nat Rev Immunol</source><year>2017</year><volume>17</volume><issue>3</issue><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.138</pub-id><?supplied-pmid 28111475?><pub-id pub-id-type="pmid">28111475</pub-id></element-citation></ref><ref id="CR43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Audet</surname><given-names>J</given-names></name><name><surname>Bello</surname><given-names>A</given-names></name><name><surname>Fernando</surname><given-names>L</given-names></name><name><surname>Alimonti</surname><given-names>JB</given-names></name><name><surname>Fausther-Bovendo</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Aviles</surname><given-names>J</given-names></name><name><surname>Hiatt</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Morton</surname><given-names>J</given-names></name><name><surname>Swope</surname><given-names>K</given-names></name><name><surname>Bohorov</surname><given-names>O</given-names></name><name><surname>Bohorova</surname><given-names>N</given-names></name><name><surname>Goodman</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Pauly</surname><given-names>MH</given-names></name><name><surname>Velasco</surname><given-names>J</given-names></name><name><surname>Pettitt</surname><given-names>J</given-names></name><name><surname>Olinger</surname><given-names>GG</given-names></name><name><surname>Whaley</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Strong</surname><given-names>JE</given-names></name><name><surname>Zeitlin</surname><given-names>L</given-names></name><name><surname>Kobinger</surname><given-names>GP</given-names></name></person-group><article-title>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</article-title><source>Nature</source><year>2014</year><volume>514</volume><issue>7520</issue><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nature13777</pub-id><?supplied-pmid 25171469?><pub-id pub-id-type="pmid">25171469</pub-id></element-citation></ref><ref id="CR44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzi</surname><given-names>A</given-names></name><name><surname>Robertson</surname><given-names>SJ</given-names></name><name><surname>Haddock</surname><given-names>E</given-names></name><name><surname>Feldmann</surname><given-names>F</given-names></name><name><surname>Hanley</surname><given-names>PW</given-names></name><name><surname>Scott</surname><given-names>DP</given-names></name><name><surname>Strong</surname><given-names>JE</given-names></name><name><surname>Kobinger</surname><given-names>G</given-names></name><name><surname>Best</surname><given-names>SM</given-names></name><name><surname>Feldmann</surname><given-names>H</given-names></name></person-group><article-title>EBOLA VACCINE, VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain</article-title><source>Science</source><year>2015</year><volume>349</volume><issue>6249</issue><fpage>739</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1126/science.aab3920</pub-id><?supplied-pmid 26249231?><pub-id pub-id-type="pmid">26249231</pub-id></element-citation></ref><ref id="CR45"><label>45</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>M</given-names></name><name><surname>May</surname><given-names>RM</given-names></name></person-group><source>Virus Dynamics : Mathematical Principles of Immunology and Virology: Mathematical Principles of Immunology and Virology</source><year>2000</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Nabel</surname><given-names>GJ</given-names></name></person-group><article-title>Ebola virus pathogenesis: implications for vaccines and therapies,</article-title><source>J Virol</source><year>2003</year><volume>77</volume><issue>18</issue><fpage>9733</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.18.9733-9737.2003</pub-id><?supplied-pmid 12941881?><pub-id pub-id-type="pmid">12941881</pub-id></element-citation></ref><ref id="CR47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madelain</surname><given-names>V</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name><name><surname>Olivo</surname><given-names>A</given-names></name><name><surname>de Lamballerie</surname><given-names>X</given-names></name><name><surname>Guedj</surname><given-names>J</given-names></name><name><surname>Taburet</surname><given-names>AM</given-names></name><name><surname>Mentre</surname><given-names>F</given-names></name></person-group><article-title>Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials</article-title><source>Clin Pharmacokinet</source><year>2016</year><volume>55</volume><issue>8</issue><fpage>907</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s40262-015-0364-1</pub-id><?supplied-pmid 26798032?><pub-id pub-id-type="pmid">26798032</pub-id></element-citation></ref><ref id="CR48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henao-Restrepo</surname><given-names>AM</given-names></name><name><surname>Camacho</surname><given-names>A</given-names></name><name><surname>Longini</surname><given-names>IM</given-names></name><name><surname>Watson</surname><given-names>CH</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Carroll</surname><given-names>MW</given-names></name><name><surname>Dean</surname><given-names>NE</given-names></name><name><surname>Diatta</surname><given-names>I</given-names></name><name><surname>Doumbia</surname><given-names>M</given-names></name><name><surname>Draguez</surname><given-names>B</given-names></name><name><surname>Duraffour</surname><given-names>S</given-names></name><name><surname>Enwere</surname><given-names>G</given-names></name><name><surname>Grais</surname><given-names>R</given-names></name><name><surname>Gunther</surname><given-names>S</given-names></name><name><surname>Gsell</surname><given-names>PS</given-names></name><name><surname>Hossmann</surname><given-names>S</given-names></name><name><surname>Watle</surname><given-names>SV</given-names></name><name><surname>Konde</surname><given-names>MK</given-names></name><name><surname>Keita</surname><given-names>S</given-names></name><name><surname>Kone</surname><given-names>S</given-names></name><name><surname>Kuisma</surname><given-names>E</given-names></name><name><surname>Levine</surname><given-names>MM</given-names></name><name><surname>Mandal</surname><given-names>S</given-names></name><name><surname>Mauget</surname><given-names>T</given-names></name><name><surname>Norheim</surname><given-names>G</given-names></name><name><surname>Riveros</surname><given-names>X</given-names></name><name><surname>Soumah</surname><given-names>A</given-names></name><name><surname>Trelle</surname><given-names>S</given-names></name><name><surname>Vicari</surname><given-names>AS</given-names></name><name><surname>Rottingen</surname><given-names>JA</given-names></name><name><surname>Kieny</surname><given-names>MP</given-names></name></person-group><article-title>Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola &#x000c7;a Suffit!)</article-title><source>Lancet</source><year>2017</year><volume>389</volume><issue>10068</issue><fpage>505</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)32621-6</pub-id><?supplied-pmid 28017403?><pub-id pub-id-type="pmid">28017403</pub-id></element-citation></ref><ref id="CR49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>HJ</given-names></name><name><surname>Chen</surname><given-names>HY</given-names></name><name><surname>Ji</surname><given-names>YJ</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Rong</surname><given-names>YH</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Liu</surname><given-names>LM</given-names></name><name><surname>Jin</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>N</given-names></name><name><surname>Su</surname><given-names>HB</given-names></name><name><surname>Teng</surname><given-names>GJ</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>EQ</given-names></name><name><surname>Jia</surname><given-names>HJ</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>TS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>JS</given-names></name><name><surname>Yan</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>ZW</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Nie</surname><given-names>WM</given-names></name><name><surname>Jiang</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>XD</given-names></name><name><surname>Ji</surname><given-names>D</given-names></name><name><surname>Zhuang</surname><given-names>YJ</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>LF</given-names></name><name><surname>Li</surname><given-names>WG</given-names></name><name><surname>Duan</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Sun</surname><given-names>ZQ</given-names></name><name><surname>Kanu</surname><given-names>AB</given-names></name><name><surname>Koroma</surname><given-names>SM</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>FS</given-names></name></person-group><article-title>Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients</article-title><source>Int J Infect Dis</source><year>2016</year><volume>42</volume><fpage>34</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2015.10.021</pub-id><?supplied-pmid 26523640?><pub-id pub-id-type="pmid">26523640</pub-id></element-citation></ref><ref id="CR50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Cunningham-Rundles</surname><given-names>C</given-names></name></person-group><article-title>Assessment and clinical interpretation of reduced IgG values</article-title><source>Ann Allergy Asthma Immunol</source><year>2007</year><volume>99</volume><issue>3</issue><fpage>281</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/S1081-1206(10)60665-5</pub-id><?supplied-pmid 17910333?><pub-id pub-id-type="pmid">17910333</pub-id></element-citation></ref><ref id="CR51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldmann</surname><given-names>H</given-names></name><name><surname>Geisbert</surname><given-names>TW</given-names></name></person-group><article-title>Ebola haemorrhagic fever,</article-title><source>Lancet (London, England)</source><year>2011</year><volume>377</volume><issue>9768</issue><fpage>849</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)60667-8</pub-id></element-citation></ref><ref id="CR52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerlund</surname><given-names>E</given-names></name><name><surname>Prescott</surname><given-names>J</given-names></name><name><surname>Tampellini</surname><given-names>L</given-names></name></person-group><article-title>Shedding of Ebola virus in an asymptomatic pregnant woman,</article-title><source>N Engl J Med</source><year>2015</year><volume>372</volume><issue>25</issue><fpage>2467</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1503275</pub-id><?supplied-pmid 26083224?><pub-id pub-id-type="pmid">26083224</pub-id></element-citation></ref><ref id="CR53"><label>53</label><mixed-citation publication-type="other">Statistics Sierra Leone (SSL) and ICF International. Sierra Leone Demographic and Health Survey 2013: Freetown, Sierra Leone and Rockville, Maryland, USA: SSL and ICF International; 2014.</mixed-citation></ref><ref id="CR54"><label>54</label><mixed-citation publication-type="other">World Health Organization. What We Know About Transmission of the Ebola Virus Among Humans: Ebola situation assessment; 2014. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/news/ebola/06-october-2014/en/">http://www.who.int/mediacentre/news/ebola/06-october-2014/en/</ext-link>.</mixed-citation></ref><ref id="CR55"><label>55</label><mixed-citation publication-type="other">Lipton J. Care and burial practices in urban Sierra Leone. 2014. <ext-link ext-link-type="uri" xlink:href="http://www.ebola-anthropology.net/wp-content/uploads/2014/11/care-and-burial-practice.pdf">http://www.ebola-anthropology.net/wp-content/uploads/2014/11/care-and-burial-practice.pdf</ext-link>.</mixed-citation></ref><ref id="CR56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>Bauch</surname><given-names>CT</given-names></name><name><surname>Eames</surname><given-names>KT</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Galvani</surname><given-names>AP</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name></person-group><article-title>Nine challenges in incorporating the dynamics of behaviour in infectious diseases models</article-title><source>Epidemics</source><year>2015</year><volume>10</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2014.09.005</pub-id><?supplied-pmid 25843377?><pub-id pub-id-type="pmid">25843377</pub-id></element-citation></ref><ref id="CR57"><label>57</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>R Core Team</collab></person-group><source>R: A Language and Environment for Statistical Computing</source><year>2015</year><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name></element-citation></ref><ref id="CR58"><label>58</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Soetaert</surname><given-names>K</given-names></name><name><surname>Cash</surname><given-names>J</given-names></name><name><surname>Mazzia</surname><given-names>F</given-names></name></person-group><source>Solving Differential Equations in R</source><year>2012</year><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csardi</surname><given-names>G</given-names></name><name><surname>Nepusz</surname><given-names>T</given-names></name></person-group><article-title>The igraph software package for complex network research</article-title><source>InterJournal</source><year>2006</year><volume>Complex Systems</volume><fpage>1695</fpage></element-citation></ref><ref id="CR60"><label>60</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>List of Blueprint priority diseases</source><year>2018</year><publisher-loc>Cambridge</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="CR61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csardi</surname><given-names>G</given-names></name><name><surname>Nepusz</surname><given-names>T</given-names></name></person-group><article-title>The igraph software package for complex network research</article-title><source>InterJournal</source><year>2006</year><volume>Complex Systems</volume><fpage>1695</fpage></element-citation></ref><ref id="CR62"><label>62</label><mixed-citation publication-type="other">Peixoto TP. The graph-tool python library. figshare. 2014. 10.6084/m9.figshare.1164194. Accessed 10 Sep 2014.</mixed-citation></ref><ref id="CR63"><label>63</label><mixed-citation publication-type="other">World Health Organization. Immunization Coverage: Geneva: World Health Organization; 2010.</mixed-citation></ref><ref id="CR64"><label>64</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Keeling</surname><given-names>MJ</given-names></name><name><surname>Rohani</surname><given-names>P</given-names></name></person-group><source>Modeling Infectious Diseases in Humans and Animals</source><year>2011</year><publisher-loc>Princeton</publisher-loc><publisher-name>Princeton University Press</publisher-name></element-citation></ref><ref id="CR65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>CJE</given-names></name><name><surname>Andreasen</surname><given-names>V</given-names></name><name><surname>Bj&#x000f8;rnstad</surname><given-names>ON</given-names></name><name><surname>Eames</surname><given-names>K</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Hollingsworth</surname><given-names>TD</given-names></name><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Seven challenges in modeling vaccine preventable diseases</article-title><source>Epidemics</source><year>2015</year><volume>10</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2014.08.004</pub-id><?supplied-pmid 25843375?><pub-id pub-id-type="pmid">25843375</pub-id></element-citation></ref><ref id="CR66"><label>66</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention and World Health Organization. Implementation and Management of Contact Tracing for Ebola Virus Disease: Emergency Guideline. 2015.</mixed-citation></ref><ref id="CR67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiura</surname><given-names>H</given-names></name></person-group><article-title>Early efforts in modeling the incubation period of infectious diseases with an acute course of illness</article-title><source>Emerg Themes Epidemiol</source><year>2007</year><volume>4</volume><issue>1</issue><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1742-7622-4-2</pub-id><?supplied-pmid 17466070?><pub-id pub-id-type="pmid">17466070</pub-id></element-citation></ref><ref id="CR68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obadia</surname><given-names>T</given-names></name><name><surname>Haneef</surname><given-names>R</given-names></name><name><surname>Boelle</surname><given-names>PY</given-names></name></person-group><article-title>The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks</article-title><source>BMC Med Inform Decis Mak</source><year>2012</year><volume>12</volume><fpage>147</fpage><pub-id pub-id-type="doi">10.1186/1472-6947-12-147</pub-id><?supplied-pmid 23249562?><pub-id pub-id-type="pmid">23249562</pub-id></element-citation></ref><ref id="CR69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virlogeux</surname><given-names>V</given-names></name><name><surname>Fang</surname><given-names>VJ</given-names></name><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><article-title>Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>35839</fpage><pub-id pub-id-type="doi">10.1038/srep35839</pub-id><?supplied-pmid 27775012?><pub-id pub-id-type="pmid">27775012</pub-id></element-citation></ref><ref id="CR70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>MJ</given-names></name><name><surname>Salim</surname><given-names>AM</given-names></name><name><surname>Hurtado</surname><given-names>JC</given-names></name><name><surname>Kilgore</surname><given-names>PE</given-names></name></person-group><article-title>Ebola Virus Infection: Overview and Update on Prevention and Treatment</article-title><source>Infect Dis Ther</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>365</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/s40121-015-0079-5</pub-id><?supplied-pmid 26363787?><pub-id pub-id-type="pmid">26363787</pub-id></element-citation></ref><ref id="CR71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastor-Satorras</surname><given-names>R</given-names></name><name><surname>Castellano</surname><given-names>C</given-names></name><name><surname>Van Mieghem</surname><given-names>P</given-names></name><name><surname>Vespignani</surname><given-names>A</given-names></name></person-group><article-title>Epidemic processes in complex networks</article-title><source>Rev Mod Phys</source><year>2015</year><volume>87</volume><issue>3</issue><fpage>925</fpage><pub-id pub-id-type="doi">10.1103/RevModPhys.87.925</pub-id></element-citation></ref><ref id="CR72"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bisset</surname><given-names>KR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Kumar</surname><given-names>VSA</given-names></name><name><surname>Marathe</surname><given-names>MV</given-names></name></person-group><source>EpiFast: a Fast Algorithm for Large Scale Realistic Epidemic Simulations on Distributed Memory Systems. a fast algorithm for large scale realistic epidemic simulations on distributed memory systems</source><year>2009</year><publisher-loc>New York, New York, USA</publisher-loc><publisher-name>ACM</publisher-name></element-citation></ref><ref id="CR73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heffernan</surname><given-names>JM</given-names></name><name><surname>Smith</surname><given-names>RJ</given-names></name><name><surname>Wahl</surname><given-names>LM</given-names></name></person-group><article-title>Perspectives on the basic reproductive ratio</article-title><source>Journal of The Royal Society Interface</source><year>2005</year><volume>2</volume><issue>4</issue><fpage>281</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1098/rsif.2005.0042</pub-id></element-citation></ref><ref id="CR74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>A</given-names></name><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Breman</surname><given-names>J</given-names></name><name><surname>Piot</surname><given-names>P</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name></person-group><article-title>Potential for large outbreaks of Ebola virus disease</article-title><source>Epidemics</source><year>2014</year><volume>9</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.epidem.2014.09.003</pub-id><?supplied-pmid 25480136?><pub-id pub-id-type="pmid">25480136</pub-id></element-citation></ref><ref id="CR75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name><name><surname>Meyers</surname><given-names>LA</given-names></name></person-group><article-title>When individual behaviour matters: homogeneous and network models in epidemiology</article-title><source>J R Soc Interface</source><year>2007</year><volume>4</volume><issue>16</issue><fpage>879</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1098/rsif.2007.1100</pub-id><?supplied-pmid 17640863?><pub-id pub-id-type="pmid">17640863</pub-id></element-citation></ref><ref id="CR76"><label>76</label><mixed-citation publication-type="other">Abbas AK. B Cell Activation and Antibody Production. In: Cellular and Molecular Immunology. Elsevier Health Sciences: 2011. p. 1&#x02013;26.</mixed-citation></ref><ref id="CR77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vegvari</surname><given-names>C</given-names></name><name><surname>Hadjichrysanthou</surname><given-names>C</given-names></name><name><surname>Cau&#x000eb;t</surname><given-names>E</given-names></name><name><surname>Lawrence</surname><given-names>E</given-names></name><name><surname>Cori</surname><given-names>A</given-names></name><name><surname>de Wolf</surname><given-names>F</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name></person-group><article-title>How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>7</issue><fpage>0158237</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0158237</pub-id></element-citation></ref><ref id="CR78"><label>78</label><mixed-citation publication-type="other">Bowman A, Azzalini A. R Package sm: Nonparametric Smoothing Methods (version 2.2-5.4). 2014.</mixed-citation></ref><ref id="CR79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Kerkhove</surname><given-names>MD</given-names></name><name><surname>Bento</surname><given-names>AI</given-names></name><name><surname>Mills</surname><given-names>HL</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name></person-group><article-title>A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making</article-title><source>Sci Data</source><year>2015</year><volume>2</volume><fpage>150019</fpage><pub-id pub-id-type="doi">10.1038/sdata.2015.19</pub-id><?supplied-pmid 26029377?><pub-id pub-id-type="pmid">26029377</pub-id></element-citation></ref></ref-list></back></article>